Asset-Level Medical Strategy Execution: Develop and implement the Global Medical Affairs plan for Ilumetri aligned with the biologics portfolio strategy, with emphasis on post‑launch lifecycle optimization; ensure tactical execution of medical plans within agreed global priorities and governance frameworks.
Scientific & Evidence Excellence: Execute asset‑level evidence activities focused on evidence maturation, comparative positioning and long‑term value demonstration, aligned with portfolio‑level IEGP and RWE strategies; lead scientific exchange, publications and data dissemination to reinforce Ilumetri’s established profile.
Cross‑Functional Collaboration: Collaborate with R&D, Market Access, Commercial, Regulatory and Global RWE teams to support sustained value, access and differentiation; contribute Ilumetri‑specific medical insights to global forums via the VP Global Medical Affairs, Biologics.